Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind controlled trial of AlloJoin for knee osteoarthritis
CTR20192352Phase 2Active
- Sponsor
- Cellular Biomedicine Group
- Start
- May 2020
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic adipose-derived stromal/stem cells in knee osteoarthritis (OA), sponsored by Cellular Biomedicine Group. Started May 2020; status: active.
02
Drugs
allogeneic adipose-derived stromal/stem cells
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on CTR20192352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192352.